Popular search terms:
Search Results
116 results found-
We encourage you to make your well-being a priority. It's important and so are you.
https://www.cslbehring.ca/careers/how-we-care-for-you-at-csl -
Our environment is collaborative, global and dynamic, which fosters innovation and motivates the best and brightest to succeed. Can you see yourself at CSL?
https://www.cslbehring.ca/careers/see-yourself -
January is National Mentoring Month, but some seek STEM-focused learning year-round.
https://www.cslbehring.ca/news/2018/20180130-mentoring-month -
concern for safety might be well based, but you cannot We support learning and development and encourage our prejudge the ability of a disabled candidate to perform employees to develop their careers within the CSL Group the role.
https://www.cslbehring.ca/-/media/csl/documents/crbp-languages/csl_crbp2021_english_external.pdf -
CSL is committed to building a workplace where employees can have promising futures by fulfilling their career aspirations, realizing their potential and being part of a purpose-driven company with a Values-based culture.
https://www.cslbehring.ca/-/media/shared/documents/csl-diversity-statement-english.pdf -
Dr. Andrea Douglas of CSL Behring discusses bringing women into STEM fields and raising them to the executive ranks.
https://www.cslbehring.ca/news/2018/20180124-women-in-stem -
Welcome to CSL Behring Canada. Our portfolio of innovative medicines includes a wide range of recombinant and plasma-derived products for treating bleeding disorders, immune deficiencies, and chronic inflammatory demyelinating polyneuropathy, as well as hereditary angioedema and Alpha-1 Antitrypsin Deficiency.
https://www.cslbehring.ca/news/2019/38th-annual-john-molson -
Results in missed opportunities in terms of school and career, as well as significant absences from work for both patients and carers
https://www.cslbehring.ca/-/media/shared/documents/7/rd-investor-briefing-2015.pdf -
Bienvenue chez CSL Behring Canada. Notre panoplie de médicaments innovants comprend une large gamme de produits recombinants et dérivés du plasma pour le traitement des troubles de la coagulation, des déficits immunitaires et de la polyneuropathie démyélinisante inflammatoire chronique, ainsi que l'angio-œdème héréditaire et le déficit en alpha-1 antitrypsine.
https://www.cslbehring.ca/fr-fr/nouvelles/2023/csl-again-named-among-americas-best-employers-by-forbes